Structures by: Lennie A. R.
Total: 167
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.760(2)Å b=6.1455(12)Å c=8.737(4)Å
α=76.06(3)° β=84.56(3)° γ=81.25(2)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.728(2)Å b=6.0501(14)Å c=8.684(5)Å
α=76.54(3)° β=84.73(4)° γ=81.67(3)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.693(2)Å b=5.9013(14)Å c=8.599(5)Å
α=77.48(3)° β=84.97(4)° γ=82.35(3)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.676(3)Å b=5.8115(17)Å c=8.543(6)Å
α=77.95(4)° β=85.11(5)° γ=82.77(4)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.5100(5)Å b=5.9287(6)Å c=8.503(3)Å
α=76.528(16)° β=85.624(17)° γ=83.203(8)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.4832(4)Å b=5.8932(4)Å c=8.465(2)Å
α=76.234(13)° β=85.836(13)° γ=83.284(6)°
C7H6Cl1N3O4S2
C7H6Cl1N3O4S2
CrystEngComm (2010) 12, 9 2533
a=4.4609(4)Å b=5.8592(5)Å c=8.427(2)Å
α=75.991(15)° β=86.055(14)° γ=83.349(6)°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6168(2)Å b=15.2552(5)Å c=52.3376(16)Å
α=90° β=89.976(2)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.3592(7)Å b=14.601(2)Å c=51.188(9)Å
α=90° β=89.989(10)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.2634(3)Å b=14.4120(11)Å c=50.836(4)Å
α=90° β=89.966(5)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6837(2)Å b=15.5843(6)Å c=52.1546(16)Å
α=90° β=89.933(2)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.1346(6)Å b=14.165(2)Å c=50.433(8)Å
α=90° β=89.880(9)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.701(2)Å b=12.569(6)Å c=24.786(13)Å
α=90° β=90° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.0316(6)Å b=14.0254(19)Å c=50.157(8)Å
α=90° β=89.796(9)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6475(7)Å b=12.451(3)Å c=24.651(2)Å
α=90° β=90° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6285(8)Å b=12.299(3)Å c=24.555(3)Å
α=90° β=90° γ=90°
[Mn3(BPy)4(cht)2][ClO4]3
[Mn3(BPy)4(cht)2][ClO4]3
Dalton transactions (Cambridge, England : 2003) (2009) 36 7390-7395
a=11.331(2)Å b=21.547(4)Å c=12.817(3)Å
α=90° β=93.67(3)° γ=90°
[Mn3(BPy)4(cht)2][ClO4]3
[Mn3(BPy)4(cht)2][ClO4]3
Dalton transactions (Cambridge, England : 2003) (2009) 36 7390-7395
a=11.549(2)Å b=21.720(4)Å c=12.991(3)Å
α=90° β=94.04(3)° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.4715(4)Å b=11.4963(5)Å c=13.0802(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.431(3)Å b=11.438(7)Å c=13.018(3)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.0252(5)Å b=11.0298(14)Å c=12.3350(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.1517(6)Å b=11.1659(16)Å c=12.5744(7)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.9440(5)Å b=10.9336(14)Å c=12.1698(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.8854(5)Å b=10.8632(14)Å c=12.0516(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.8458(5)Å b=10.8143(14)Å c=11.9708(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.8188(6)Å b=10.7838(17)Å c=11.9105(8)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.7881(13)Å b=10.735(2)Å c=11.859(2)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.7873(10)Å b=10.710(2)Å c=11.8632(12)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.9233(2)Å b=19.0222(5)Å c=5.3030(2)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.8922(2)Å b=19.0021(19)Å c=5.2919(2)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.7622(2)Å b=18.7945(19)Å c=5.2343(2)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.5490(3)Å b=18.259(3)Å c=5.1169(3)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4955(4)Å b=18.000(4)Å c=5.0930(4)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4885(14)Å b=17.834(7)Å c=5.0983(13)Å
α=90° β=90° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.5299(5)Å b=7.6432(6)Å c=11.6081(9)Å
α=90° β=93.590(5)° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.6284(3)Å b=18.508(3)Å c=5.1615(3)Å
α=90° β=90° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.3782(3)Å b=7.4754(3)Å c=11.4450(13)Å
α=90° β=92.591(7)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=10.2176(8)Å b=8.2463(5)Å c=12.6853(17)Å
α=90° β=114.238(9)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.9602(9)Å b=8.1894(6)Å c=12.475(2)Å
α=90° β=113.060(11)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.7934(8)Å b=8.1603(5)Å c=12.3534(17)Å
α=90° β=112.384(9)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.7046(5)Å b=8.1477(3)Å c=12.3071(13)Å
α=90° β=112.034(6)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.6213(11)Å b=8.1290(8)Å c=12.298(3)Å
α=90° β=112.049(13)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.5437(17)Å b=8.1824(12)Å c=12.151(4)Å
α=90° β=111.30(2)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.564(7)Å b=10.0876(18)Å c=7.6419(12)Å
α=90° β=96.38(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=9.3214(11)Å b=10.5932(12)Å c=7.6988(9)Å
α=90° β=95.059(8)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.868(9)Å b=10.2833(16)Å c=7.7016(13)Å
α=90° β=95.88(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.367(8)Å b=9.9317(17)Å c=7.5667(12)Å
α=90° β=96.49(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.254(4)Å b=9.8542(15)Å c=7.5245(11)Å
α=90° β=96.63(3)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=7.938(7)Å b=9.754(3)Å c=7.481(2)Å
α=90° β=97.03(6)° γ=90°
3-aza-bicyclo(3.3.1)nonane-2,4-dione
C8H11N1O2
Crystal Growth & Design (2008) 8, 2 549
a=8.054(7)Å b=9.782(3)Å c=7.5043(19)Å
α=90° β=96.80(5)° γ=90°
C6H10N2O2
C6H10N2O2
Crystal Growth & Design (2007) 7, 6 1115
a=6.321(2)Å b=6.5597(11)Å c=8.380(4)Å
α=79.82(3)° β=102.34(3)° γ=90.94(2)°
C6H10N2O2
C6H10N2O2
Crystal Growth & Design (2007) 7, 6 1115
a=6.442(2)Å b=6.3530(11)Å c=8.737(3)Å
α=81.43(3)° β=112.88(2)° γ=91.38(2)°
C6H10N2O2
C6H10N2O2
Crystal Growth & Design (2007) 7, 6 1115
a=6.3903(7)Å b=6.2932(11)Å c=8.6450(16)Å
α=81.106(12)° β=113.680(12)° γ=91.295(11)°
C6H10N2O2
C6H10N2O2
Crystal Growth & Design (2007) 7, 6 1115
a=6.169(2)Å b=6.1602(11)Å c=8.287(3)Å
α=80.41(3)° β=115.33(3)° γ=91.15(2)°
C6H10N2O2
C6H10N2O2
Crystal Growth & Design (2007) 7, 6 1115
a=6.263(2)Å b=6.2063(10)Å c=8.412(3)Å
α=80.77(3)° β=114.69(2)° γ=91.12(2)°
C6H10N2O2,2(H2O)
C6H10N2O2,2(H2O)
Crystal Growth & Design (2007) 7, 6 1115
a=6.217(2)Å b=7.0356(9)Å c=10.0593(13)Å
α=84.711(12)° β=76.83(2)° γ=75.77(2)°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.748(2)Å b=3.5954(3)Å c=13.6496(15)Å
α=90° β=93.115(13)° γ=90°
C7H4Mn1O5,2(H2O)
C7H4Mn1O5,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 24 6401-6410
a=9.0659(2)Å b=9.0659(2)Å c=21.7273(5)Å
α=90° β=90° γ=120°
[Cu2(OH)2(bipy)2][BF4]2
[Cu2(OH)2(bipy)2][BF4]2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 1 113-123
a=12.628(2)Å b=14.716(3)Å c=6.0524(6)Å
α=90° β=113.837(9)° γ=90°
Catena-((μ~2~-Benzoato-O,O)-bis(μ~2~-benzoato-O,O',O')-(dimethylformamide-O )-gadolinium)
(C24H22Gd1N1O7)n
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7004-7011
a=21.0414(2)Å b=21.0414(2)Å c=8.95130(10)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.3105(3)Å b=11.4299(6)Å c=5.5015(3)Å
α=90° β=90° γ=90°
C3D7NO2
C3D7NO2
CrystEngComm (2010) 12, 9 2573
a=5.2626(3)Å b=11.3404(6)Å c=5.4786(3)Å
α=90° β=90° γ=90°
C12H8Cu2O14,4(CH6N3),2(H2O)
C12H8Cu2O14,4(CH6N3),2(H2O)
CrystEngComm (2010) 12, 9 2516
a=11.2728(8)Å b=13.8681(11)Å c=18.219(4)Å
α=90° β=90° γ=90°
[Mn3(BPy)4(cht)2][ClO4]3
[Mn3(BPy)4(cht)2][ClO4]3
Dalton transactions (Cambridge, England : 2003) (2009) 36 7390-7395
a=11.897(2)Å b=22.067(4)Å c=13.312(3)Å
α=90° β=93.82(3)° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.778(2)Å b=10.656(4)Å c=11.884(3)Å
α=90° β=90° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4946(4)Å b=7.6198(3)Å c=11.5599(17)Å
α=90° β=93.306(7)° γ=90°
Mackinawite
FeS
Mineralogical Magazine (1995) 59, 677-683
a=3.6735Å b=3.6735Å c=5.0328Å
α=90° β=90° γ=90°